The table below shows Aura Biosciences, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$84.74M
-$79.81M
-$63.85M
-$54.60M
-$32.41M
-$24.32M
Capital expenditure
$447.00K
$1.25M
$709.00K
$1.09M
$2.13M
$771.00K
Investing cash flow
$35.59M
$68.82M
-$113.96M
-$67.87M
-$2.13M
-$771.00K
Dividends paid
-
-
-
-
AURA operating cash flow (10-K history)
Aura Biosciences, Inc. reported operating cash flow of -$84.74M for fiscal year 2025. That is down 6.2% from -$79.81M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$24.32M (FY 2020) to -$84.74M. Figures come from the company's audited annual reports as filed with the SEC.